<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>LY532951</GBSeq_locus>
    <GBSeq_length>1491</GBSeq_length>
    <GBSeq_strandedness>double</GBSeq_strandedness>
    <GBSeq_moltype>DNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>PAT</GBSeq_division>
    <GBSeq_update-date>26-SEP-2018</GBSeq_update-date>
    <GBSeq_create-date>26-SEP-2018</GBSeq_create-date>
    <GBSeq_definition>KR 1020170122750-A/3: EQUINE IMMUNOGLOBULIN COMPOSITIONS AND USES FOR TREATING FILOVIRUS-MEDIATED DISEASES</GBSeq_definition>
    <GBSeq_primary-accession>LY532951</GBSeq_primary-accession>
    <GBSeq_accession-version>LY532951.1</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>dbj|LY532951.1|</GBSeqid>
      <GBSeqid>pat|KR|1020170122750|3</GBSeqid>
      <GBSeqid>gi|1483451525</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_keywords>
      <GBKeyword>KR 1020170122750-A/3</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>Ebola virus (EBOV)</GBSeq_source>
    <GBSeq_organism>Ebola virus</GBSeq_organism>
    <GBSeq_taxonomy>Viruses; ssRNA viruses; ssRNA negative-strand viruses; Mononegavirales; Filoviridae; Ebolavirus</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..1491</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Holtsberg,F.W.</GBAuthor>
          <GBAuthor>Aman,M.J.</GBAuthor>
          <GBAuthor>Walz,P.H.</GBAuthor>
          <GBAuthor>Ostrowski,S.R.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>EQUINE IMMUNOGLOBULIN COMPOSITIONS AND USES FOR TREATING FILOVIRUS-MEDIATED DISEASES</GBReference_title>
        <GBReference_journal>KR1020170122750-A 3 06-NOV-2017 INTEGRATED BIOTHERAPEUTICS, INC.|AUBURN UNIVERSITY</GBReference_journal>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>KN KR 1020177023643-A/3~AN KR 1020177023643~AD 2017-08-24~PN KR 1020170122750~PD 2017-11-06~AT EQUINE IMMUNOGLOBULIN COMPOSITIONS AND USES FOR TREATING~AT FILOVIRUS-MEDIATED DISEASES~AI Holtsberg, Frederick Wayne|Aman, Mohammad Javad|Walz, Paul~AI H.|Ostrowski, Stephanie R.~AA INTEGRATED BIOTHERAPEUTICS, INC.|AUBURN UNIVERSITY~PR US 62/109,042=2015-01-28~OS Ebola virus~TY DNA~FH Key Location/Qualifiers.</GBSeq_comment>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..1491</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>1491</GBInterval_to>
            <GBInterval_accession>LY532951.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>Ebola virus</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>unassigned DNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:1570291</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>atgggtgttacgggcatactgcagctgcctcgcgaccgtttcaagcgtacgtctttcttcttgtgggtcattatcctcttccagagaactttctcaattccactcggagtgatacataatagtactttgcaagtttccgacgtggacaagttggtttgtcgtgataaactgtcatcgaccaaccaactccgttctgttggactcaacctcgaaggcaacggtgtggcaactgacgtcccatccgccaccaaaaggtggggatttcgctccggagtgccccctaaagtggtcaattatgaagcaggtgaatgggctgagaattgctacaatttggagatcaagaaacccgacggatctgagtgccttccagcagcgcccgacggtatccgtggcttcccacgttgccgctacgtgcacaaggtcagtggcactggtccgtgcgctggcgacttcgctttccacaaggagggcgcatttttcctctacgaccgtcttgcatctaccgtcatctacagaggcacaacgttcgctgagggtgtggtagcgttcctgatattgccccaggctaagaaggacttcttcagtagccaccctttgcgcgagcctgtcaacgccactgaagatccttcatctggttactactcgactaccattaggtaccaggctacgggcttcggtaccaacgaaaccgagtacctcttcgaagtcgacaaccttacttatgtgcagctggagagccgcttcacgccccagtttctcttgcagctgaacgagacaatctacaccagcggaaagaggtccaacactaccggtaaactgatttggaaagtaaaccctgaaattgacactacaataggcgagtgggccttttgggagacaaagaagaatctgaccagaaagatccgcagtgaggaactgtcattcacggttgtcaacacccaccatcaagataccggtgaggaaagcgccagttcgggaaaattgggccttattacaaacacaatcgcgggtgtggcaggcctcatcaccggaggaaggcgtacaaggcgcgaggcgatcgtaaacgctcaacctaagtgcaatcccaacttgcactattggaccactcaagacgagggtgccgctatcggcctcgcctggataccctacttcggtccagctgcggaaggtatctatacagaaggactgatgcacaaccaagatggcttgatctgcggtctgcgccaactggcaaatgagacaacgcaggccttgcagcttttccttagagcgactaccgaactgaggacattttcaattcttaatagaaaggccatcgattttctgctccaacgctggggtggaacctgtcatatacttggcccggattgttgtatcgagccacacgactggactaagaacatcaccgacaagatagatcagatcattcacgatttcgtcgataaaacactgcctgaccaccaccatcaccatcatcatcaccaccattga</GBSeq_sequence>
  </GBSeq>
